Liver cell adenoma
ICD-10 D13.4 · ICD-11 2E92.7&XH68V1

Treatment of Liver Cell Adenoma During Pregnancy

Clinical Scenario

This protocol addresses the management of hepatic adenoma (HCA) in the setting of pregnancy — a situation that requires heightened surveillance and readiness for intervention.

Pregnancy & Hepatic Adenoma

In the setting of pregnancy, hepatic adenomas may exhibit growth and progression. Regular monitoring is recommended throughout pregnancy, with intervention indicated when there is growth beyond a critical size threshold or when high-risk features for hemorrhagic rupture are present.

Treatment Approach (Partial Overview)

When hemorrhagic rupture of a hepatic adenoma occurs during pregnancy, a surgical intervention is indicated on an emergent basis.

Full protocol details — including timing, approach, and decision criteria — are available via the complete regimen below.
Instant Access to Structured Evidence-Based Regimens

References

DOI: 10.14309/ajg.0000000000002857

In the setting of pregnancy, HCAs may exhibit growth and progression.

Hepatic adenomas should be monitored regularly during pregnancy and should be treated if there is growth to >6.5 cm or with high-risk features for hemorrhagic rupture.

During the third trimester, emergent surgery is recommended for hemorrhagic rupture from HCA.

View source ↗